Association between ER and HER2neu status with various sonographic findings in breast cancer
DOI:
https://doi.org/10.70863/karbalajm.v16i2.1229Abstract
Diagnostic ultrasonography is often used as a radiological modality for assessing clinically or radiologically suspected mammary lesions based on certain radiological criteria. This study was conducted to investigate an association between breast sonographic findings and biological markers (ER and HER2\NEU). The study enrolled 100 histological sample of invasive mammary carcinoma diagnosed by core needle biopsy, 52% from the right breast and 48 % from the left one , age range of patient was from 28 to 80 years with a mean age was 53 years. 64 % were estrogen receptor positive, 54% were HER2\NEU positive. There is a significant statistical correlation between ER and HER2\NEU positivity with the simultaneous presence of axillery lymph node metastasis. While there is a non statistical relashioship between ER and HER2\NEU positivity with various sonographic findings in invasive mammary carcinoma. Thus, breast ultrasound based findings are of no help to predict ER and HER2 status of invasive mammary carcinoma.
References
Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, A.L.; Jemal, A. Global cancer statistics 2018, GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424.
Lukong KE. Understanding breast cancer - the long and winding road. BBA Clin. 2017; 7; 64–77.
Cho SY, Park SY, Bae YK et al. Standardized pathology report for breast cancer. J. Breast Cancer 2021; 24; 1–21.
Kashyap A, Rapsomaniki MA, Barros V, Fomitcheva-Khartchenko A, Martinelli AL, Rodriguez AF, et al. Quantifcation of tumor heterogeneity: from data acquisition to metric generation. Trends Biotechnol. 2022;40:647–76.
K Rabe, OL Snir, V Bossuyt, M Harigopal, R Celli, ES Reisenbichler.Interobserver variability in breast carcinoma grading results in prognostic stage differences. Hum Pathol, 94: 51-57.2019.
Oetz MP., Gradishar WJ., Anderson BO. NCCN Guidelines Insights: Breast Cancer, Version 3.2018. 2019. J Natl Compr Canc Netw. ,17(2):118–126,2019.
Allison KH, Hammond ME, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J, Perou CM. Estrogen and progesterone receptor testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists guideline update. Archives of pathology & laboratory medicine. 2020 May 1;144(5):545-63.
Raj-Kumar P.-K., Liu J., Hooke J.A., Kovatich A.J., Kvecher L., Shriver C.D., Hu H. PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B. Sci. Rep,,9(1):7956.2019.
Tsang JY, Gary MT. Molecular classification of breast cancer. Advances in anatomic pathology. 2020 Jan 1;27(1):27-35.
Li Z, Wei H, Li S, Wu P, Mao X. The role of progesterone receptors in breast cancer. Drug Des Devel Ther. 2022; 16: 305-314.
Li Z, Wei H, Li S, Wu P, Mao X. The role of progesterone receptors in breast cancer. Drug Des Devel Ther ,16: 305-314,2022.
Loibl S, Gianni L. HER2-positive breast cancer. Lancet. 2017; 389:2415–29.
Tarantino P, Hamilton E, Tolaney SM, Cortes J, Morganti S, Ferraro E, Marra A, Viale G, Trapani D, Cardoso F, Penault-Llorca F. HER2-low breast cancer: pathological and clinical landscape. Journal of Clinical Oncology. 2020 Jun 10;38(17):1951-62.
Zhou SC, Le J, Zhou J, Huang YX, Qian L, Chang C. The role of contrast-enhanced ultrasound in the diagnosis and pathologic response prediction in breast cancer: a meta-analysis and systematic review. Clinical Breast Cancer. 2020 Aug 1;20(4):e490-509.
Ghaemian N, Tehrani NH, Nabahati M. Accuracy of mammography and ultrasonography and their BI-RADS in detection of breast malignancy. Caspian Journal of Internal Medicine. 2021;12(4):573
Kamal MZ, Banu NR, Alam MM, Das UK, Karmoker RK. Evaluation of Breast Lump-Comparison between True-cut Needle Biopsy and FNAC in MMCH: A Study of 100 Cases. Mymensingh medical journal: MMJ. 2020 Jan 1;29(1):48-54.
M.S. Bae, S.U. Shin, S.E. Song, H.S. Ryu, W. Han, W.K. Moon. Association between US features of primary tumor and axillary lymph node metastasis in patients with clinical T1-T2N0 breast cancer. Acta Radiol,2018, 59 :402-408.
Mohson KI. Ultrasound findings in prediction of breast cancer histological grade and HER2 status. Journal of the Faculty of Medicine Baghdad. 2016 Apr 3;58(1):26-8.
Ayad AM. Predictive factors affecting axillary lymph node involvement in patients with breast cancer in Duhok: Cross-sectional study Ann Med Surg . 2019 ; 44: 87–90.
Kim SH, Seo BK, Lee J, Kim SJ, Cho KR, Lee KY, Je BK, Kim HY, Kim YS, Lee JH. Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer. Acta oncologica. 2008 Jan 1;47(8):1531-8.
BK, Pisano ED, Kuzimak CM, Koomen M, Pavic D, Lee Y, et al. Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol 2006; 13: 1211–8.
Karamouzis MV, LikakiKaratza E, Ravazoula P, Badra FA, Koukouras D, Tzorakoleftherakis E, et al. non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors. Int J Cancer 2002; 102: 86–90
Downloads
Published
How to Cite
Issue
Section
